Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $21.26 USD
Change Today +0.05 / 0.24%
Volume 57.1K
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

exactech inc (EXAC) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/30/14 - $26.52
52 Week Low
10/14/14 - $19.87
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EXACTECH INC (EXAC)

Related News

No related news articles were found.

exactech inc (EXAC) Related Businessweek News

No Related Businessweek News Found

exactech inc (EXAC) Details

Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services to hospitals and physicians in the United States and internationally. It offers knee implant systems that address orthopedic surgeons’ concerns for contact stress, patellar tracking, polyethylene wear, joint stability, bone preservation, and instrumentation; extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and hip implant systems that address hip arthroplasty, hip fractures, and complex primary hip surgeries. The company also offers biologics and spine products for the healing and regeneration of bone and soft tissues; distributes allograft tissue implants for oral and dental applications; and markets OpteMx, a tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. In addition, it provides Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; the InterSpace hip, knee, and shoulder spacers; AcuDriver, an air-driven impact handpiece that surgeons could use during joint implant revision procedures to remove failed prostheses and bone cement; and Cemex Genta bone cement. The company markets its orthopedic implant products through a network of independent sales agencies, direct sales representatives, and independent distributors to hospitals, surgeons and other physicians, and clinics. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida.

642 Employees
Last Reported Date: 03/4/15
Founded in 1985

exactech inc (EXAC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $444.8K
Co-Founder and Executive Chairman
Total Annual Compensation: $612.2K
Co-Founder and Executive Vice President of Re...
Total Annual Compensation: $337.1K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $393.5K
Senior Vice President and General Manager of ...
Total Annual Compensation: $393.5K
Compensation as of Fiscal Year 2014.

exactech inc (EXAC) Key Developments

Exactech Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Revenue Guidance for the Second Quarter Ending June 30, 2015; Provides Revenue Guidance for the Year 2015

Exactech Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $61,376,000 against $63,258,000 a year ago. Income from operations was $6,066,000 against $6,611,000 a year ago. Income before income taxes was $5,592,000 against $6,604,000 a year ago. Net income was $4,112,000 against $4,198,000 a year ago. Diluted earnings per share were $0.29 against $0.30 per share a year ago. For the year 2015, the company’s revenue guidance to $248 million to $254 million and its diluted EPS target to $1.18 to $1.24. The company expects the tax rate to be 33% to 34% for the balance of the year. For the second quarter ending June 30, 2015, the company anticipates revenues of $61 to $63 and diluted EPS of $0.26 to $0.28. The company continues to expect gross margins to decrease approximately 50 basis points on a comparative quarter basis due to the continued impact of pricing, as well as the impact of foreign exchange rates where they currently reside. The company expects to experience a compression of operating margin in the second quarter, primarily due to the impact of the FX rate.

Exactech Inc. Provides Earnings Guidance for the First Quarter Ended March 31, 2015

Exactech Inc. provides earnings guidance for the first quarter ended March 31, 2015. The company expects revenues for the quarter to be $61.4 million and diluted earnings per share for the quarter to be in the range of $0.29 - $0.30.

Exactech Inc. to Report Q1, 2015 Results on Apr 28, 2015

Exactech Inc. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on Apr 28, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAC:US $21.26 USD +0.05

EXAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aerovironment Inc $26.17 USD +0.52
Alphatec Holdings Inc $1.37 USD +0.01
Mercury Systems Inc $13.72 USD -0.01
RTI Surgical Inc $6.68 USD +0.12
SigmaTron International Inc $8.78 USD +0.03
View Industry Companies

Industry Analysis


Industry Average

Valuation EXAC Industry Range
Price/Earnings 18.2x
Price/Sales 1.2x
Price/Book 1.4x
Price/Cash Flow 8.9x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACTECH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at